Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma

Immunotherapies, including anti-PD-1 immune checkpoint blocking (ICB) antibodies, have revolutionized the treatment of many solid malignancies. However, their efficacy in breast cancer has been limited to a subset of patients with triple-negative breast cancer, where ICBs are routinely combined with...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatarova, Zuzana, Blumberg, Dylan C., Bensen, AeSoon, Mills, Gordon B., Jonas, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856407/
https://www.ncbi.nlm.nih.gov/pubmed/36672243
http://dx.doi.org/10.3390/cells12020308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856407/
https://www.ncbi.nlm.nih.gov/pubmed/36672243
http://dx.doi.org/10.3390/cells12020308

Ejemplares similares